Kröger H, Grätz R, Grahn H
Int J Biochem. 1983;15(9):1131-6. doi: 10.1016/0020-711x(83)90227-6.
After application of D-galactosamine a hepatitis develops in the rat liver. This can be prevented by different agents, including tryptophan. Yet it has not been possible to give definitive conclusions about the mechanism of galactosamine hepatitis. In this paper we report about the influence of galactosamine on the NAD metabolism. D-galactosamine inhibits the NAD synthesis initiated by nicotinamide in normal and adrenalectomized animals. The NAD synthesis from tryptophan is prevented in normal animals, in adrenalectomized ones however there is an increase of NAD in the presence of D-galactosamine reduces the activity of the ADPR transferase. Inhibitors of the ADPR transferase prevent the galactosamine hepatitis. From the results presented we conclude that the ADPR transferase plays an important role in the development of the galactosamine hepatitis.
给予D-半乳糖胺后,大鼠肝脏会发生肝炎。这可以被包括色氨酸在内的不同药物预防。然而,关于半乳糖胺肝炎的机制尚未得出明确结论。在本文中,我们报告了半乳糖胺对NAD代谢的影响。D-半乳糖胺抑制正常动物和肾上腺切除动物中由烟酰胺引发的NAD合成。正常动物中色氨酸合成NAD的过程被阻止,然而在肾上腺切除的动物中,在D-半乳糖胺存在的情况下NAD会增加,D-半乳糖胺会降低ADPR转移酶的活性。ADPR转移酶抑制剂可预防半乳糖胺肝炎。根据所呈现的结果,我们得出结论,ADPR转移酶在半乳糖胺肝炎的发展中起重要作用。